Regulatory
FTC Proposes Making Rules Affecting Endorsements and Testimonials
By Alvin Lorman, AAHP Counsel Calling fake and deceptive product reviews and endorsements “problematic” and its remedial authority “limited,” the Federal Trade Commission (FTC) has taken the first step toward…
Read MoreDevelopments on Capitol Hill of Interest for AAHP Members
Senate Leadership of Key Committees Overseeing FDA/FTC Will See Changes in Next Congress Leaders of Influential House Committee to Remain but Role Reversal Predicted By Pete Evich, Vice President, Van…
Read MoreFDA Warning Letters for Skin Tag and Mole Removal OTCs
By Alvin Lorman, AAHP Counsel The Food and Drug Administration (FDA) has reminded two OTC drug manufacturers that mole and skin tag removal are prescription-only indications. The agency issued Warning…
Read MoreHomeopathic Promoters to Note FTC is Revising its Guide on Endorsements and Testimonials
By Mark Land, AAHP President Of the thousands of homeopathic products in the marketplace, few are ever seen advertised on television — historically, the mass medium to blanket the large…
Read MoreYour NDC Numbers are About to Change
By Eric Foxman, AAHP Secretary FDA has published a proposal that will change the required National Drug Code (NDC) format from 10 to 12 digits. Once finalized, all NDC holders…
Read MoreHouse and Senate Advance FDA User Fee Reauthorization Bills
By Pete Evich In the month of June, both the House and Senate advanced separate pieces of legislation that reauthorize FDA’s prescription drug, medical device, biosimilars, and generic drug user…
Read MoreThe Status of Homeopathic Medicinal Products in the European Union
By European Coalition on Homeopathic & Anthroposophic Medicinal Products (ECHAMP) Homeopathic medicinal products have a strong foundation in the EU law. Specific EU legislation for homeopathic medicinal products has…
Read MoreFDA Seeks Accelerated Drug Approval, DSHEA, Cosmetics Legislative Reforms
By Pete Evich, AAHP Government Relations As part of the President’s FY 2023 Budget proposal, FDA has called upon Congress to take up legislation that would give the agency additional…
Read MoreThe Regulation of Homeopathic Medicines in 2022
By Mark Land, AAHP President The content in our June 2022 newsletter on regulation turned out quite different than I imagined when we discussed it at an editorial planning…
Read MoreRegulation of Homeopathic Medicines in Canada
Submitted by David Skinner, Canadian Homeopathic Pharmaceutical Association Homeopathic medicines (HMs) are regulated in Canada by Health Canada, the federal government department responsible for ensuring the safety, efficacy, and…
Read More